GSCA is an integrated genomic, pharmacogenomic, and immunogenomic web-based platform for gene set cancer research. It is an update of our previous webserver GSCALite - Git Repo.
The alterations of DNA, RNA and immune microenvironment could contribute to the cancer initiation, progress, diagnosis, prognosis, therapy. In bio-big data era, individual causal gene signal could be masked by massive background noises. A set of genes or compiled gene set scores from multiple dimensional data across a large number patients per stage could represent a snap shot of the underlying cancer process.
In this updated GSCA, we provide a series of services to perform gene set genomic (Expression, SNV, CNV and methylation) and immunogenomic (24 immune cells) analyses. Besides, combining clinical information and small molecular drugs, user could mine candidate biomarkers and valuable small drugs for better experimental design and further clinical trials. GSCA integrates over ten thousand genomic data in 33 cancer types from TCGA and over 750 small molecule drugs from GDSC and CTRP. Immunogenomic analysis was performed through our ImmuCellAI with 24 immunes cells.
- Immune: 24 immune cells correlate with gene expression, SNV, CNV and methylation
- GSEA: expression of gene set enrichment analysis across pan-cancers.
- GSVA: differential gene set variable analysis and clinical correlations.
- Expression: differential expression and clinical correlations with individual figures.
- Drug sensitivity: update new drug data and correlate expression with drug sensitivity (IC50).
- SNV: update mutational distribution, lolipop plot and survival analysis.
- CNV: update sCNV deletion and amplifications and correlates with expressiona and survival.
- Methylation: update correlates with gene set expression and survival.
